Summary
Prognostic models that predict the clinical course of a breast cancer patient are important in oncology. We propose an approach to constructing such models based on fractional polynomials in which useful transformations of the continuous factors are determined. The idea may be applied with all types of regression model, including Cox regression, the method of choice for survival-time data. We analyse a prospective study of node-positive breast cancer. Seven standard prognostic factors – age, menopausal status, tumour size, tumour grade, number of positive lymph nodes, progesterone and oestrogen receptor concentrations – were investigated in 686 patients, of whom 299 had an event for recurrence-free survival and 171 died. We determine a final model with transformations of prognostic factors and compare it with the more traditional approaches using categorized variables or assuming a straight line relationship. We conclude that analysis using fractional polynomials can extract important prognostic information which the traditional approaches may miss.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Altman, D. G., Lausen, B., Sauerbrei, W. & Schumacher, M. (1994). Dangers of using ‘optimal’ cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86: 829–835.
Balslev, I., Axelsson, C. K., Zedeler, K., Rasmussen, B. B., Carstensen, B. & Mouridsen, H. T. (1994). The Nottingham Prognostic Index applied to 9149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat 32: 281–290.
Brown, J. M., Benson, E. A. & Jones, M. (1993). Confirmation of a long-term prognostic index in breast cancer. Breast 2: 144–147.
Byar, D. P. (1984). Identification of prognostic factors. In Cancer Clinical Trials – Methods and Practice, Buyse ME, Staquet MJ, Sylvester RJ (eds), pp. 423–443. Oxford University Press, Oxford
Chung, M., Chang, H. R., Bland, K. I. & Wanebo, H. J. (1996). Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 77: 97–103.
Collett, K., Hartveit, F., Skjaerven, R. & Maehle, B. O. (1996). Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status. J Clin Pathol 49: 920–925.
Crowe, J. P., Gordon, N. H., Shenk, R. R., Zollinger, R. M. Jr, Brumberg, D. J. & Shuck, J. M. (1994). Age does not predict breast cancer outcome (with discussion). Arch Surg 129: 483–488.
Cox, D. R. (1972). Regression models and life tables (with discussion). J R Stat Soc B 34: 187–220.
Cummings, M. C., Wright, R. G., Furnival, C. M., Bain, C. J. & Siskind, V. (1995). The feasibility of retrospective grading of breast cancer histology slides derived from multiple pathology services. Breast 4: 179–182.
Elston, C. W. & Ellis, I. O. (1991). Pathological prognostic factors in breast cancer: the value of histologic grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403–410.
Galea, M. H., Blamey, R. W., Elston, C. E. & Ellis, I. O. (1992). The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22: 207–219.
Hastie, T. J. & Tibshirani, R. J. (1990). Generalized Additive Models. Chapman and Hall: New York
Kollias, J., Elston, C. W., Ellis, I. O., Robertson, J. F. R. & Blamey, R. W. (1997). Early-onset breast cancer: histopathological and prognostic considerations. Br J Cancer 75: 1318–1323.
Lagakos, S. W. (1988). The loss in efficiency from misspecifying covariates in proportional hazards regression models. Biometrika 75: 156–160.
Palta, M. & Amini, S. B. (1985). Consideration of covariates and stratification in sample size determination for survival time studies. J Chronic Dis 38: 801–809.
Pichon, M. F., Broet, P., Magdelenat, H., Delarue, J. C., Spyratos, F., Basuyau, J. P., Saez, S., Rallet, A., Courriere, P., Millon, R. & Asselain, B. (1996). Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. Br J Cancer 73: 1545–1551.
de la Rochefordiere, A., Asselain, B., Campana, F., Scholl, S. M., Fenton, J., Vilcoq, J. R., Durand, J. C., Pouillart, P., Magdelenat, H. & Fourquet, A. (1993). Age as prognostic factor in premenopausal breast carcinoma. Lancet 341: 1039–1043.
Royston, P. & Altman, D. G. (1994). Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling (with disc). Applied Statistics 43: 429–467.
Sauerbrei, W. & Royston, P. (1999). Building multivariable prognostic and diagnostic models: transformation of the predictors using fractional polynomials. J R Stat Soc A 162: 71–94.
Sauerbrei, W., Hübner, K., Schmoor, C. & Schumacher M., for the German Breast Cancer Study Group (1997). Validation of existing and development of new prognostic classification schemes in node negative breast cancer. Breast Cancer Res Treat 42: 149–163, (Erratum in Breast Cancer Res Treat 1998; 43: 191–192)
Schmoor, C. & Schumacher, M. (1997). Effects of covariate omission and categorization when analysing randomized trials with the Cox model. Stat Med 16: 225–237.
Schmoor, C., Olschewski, M. & Schumacher, M. (1996). Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies. Stat Med 15: 263–271.
Schumacher, M., Schmoor, C., Sauerbrei, W., Schauer, A., Ummenhofer, L., Gatzemeier, W. & Rauschecker H., for the German Breast Cancer Study Group (1993). The prognostic effect of histological tumour grade in node-negative breast cancer patients. Breast Cancer Res Treat 25: 235–245.
Schumacher, M., Bastert, G., Bojar, H., Hübner, K., Olschewski, M., Sauerbrei, W., Schmoor, C., Beyerle, C., Neumann, R. L. A. & Rauschecker H., for the Breast Cancer Study Group (1994). Randomized 2×2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. J Clin Oncol 12: 2086–2093.
Simon, R. & Altman, D. G. (1994). Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69: 979–985.
Walker, R. A., Lees, E., Webb, M. B. & Dearing, S. J. (1996). Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer 74: 1796–1800.
Author information
Authors and Affiliations
Consortia
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Sauerbrei, W., Royston, P., Bojar, H. et al. Modelling the effects of standard prognostic factors in node-positive breast cancer. Br J Cancer 79, 1752–1760 (1999). https://doi.org/10.1038/sj.bjc.6690279
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690279
Keywords
This article is cited by
-
Flexible two-piece distributions for right censored survival data
Lifetime Data Analysis (2023)
-
Optimal designs for health risk assessments using fractional polynomial models
Stochastic Environmental Research and Risk Assessment (2022)
-
Direct comparison of three different mathematical models in two independent datasets of EUSOMA certified centers to predict recurrence and survival in estrogen receptor-positive breast cancer: impact on clinical practice
Breast Cancer Research and Treatment (2021)
-
Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer
BMC Cancer (2018)
-
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
BMC Medicine (2012)